The findings suggest that intranasally delivered FGF-1 may reverse type 2 diabetes by targeting dysfunctional glucose-sensing neurons in the brain. Zhittya has already dosed 20 patients in this ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback